TROP-2, 5hmC, and IDH1 Expression in Anaplastic Thyroid Carcinoma.

Abstract excerpt

BACKGROUND: Anaplastic thyroid carcinoma (ATC), a highly aggressive malignancy, has no effective treatment to date. Trophoblast cell-surface antigen 2 (TROP-2), a transmembrane glycoprotein, has been suggested to be a promising novel target for sacituzumab govitecan, an antibody-drug conjugate. 5-Hydroxymethylcytosine (5hmC) has a role in tumor suppression and promoting modification. Additionally, isocitrate...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to 5-Methylcytosine
• Share to Antibodies, Monoclonal, Humanized